X Pharma Series [exclusive] Online

| Pillar | Description | |--------|-------------| | | Gene therapies, RNA-based drugs, and personalized small molecules tailored to patient genetic profiles. | | Smart Formulations | Long-acting injectables, oral peptides, and transdermal patches with AI-optimized release kinetics. | | Digital Pharma Integration | Companion apps, wearable-linked dosing, and real-world data capture embedded with each therapy. | | Sustainable Manufacturing | Continuous flow chemistry, waste-reduction processes, and cold-chain-free biologics. |

The foundational molecules establish pharmacokinetic (PK) baselines. These initial compounds are tested for metabolic stability in human liver microsomes. For example, X-02 might show excellent target affinity but poor solubility, while X-04 shows high solubility but rapid renal clearance. x pharma series